Results for “Obesity” 14 results

All 14 Health 10 Economy 3 Society 1
Obesity Surge in Young Adults Strains U.S. Medicaid Budgets
Health 25 Jun 2026
Obesity Surge in Young Adults Strains U.S. Medicaid Budgets
Cost-of-living pressures and ultra-processed foods drive caseload spike
Obesity Crisis Hits Hardest Among U.S. Young Adults
Health 05 Jul 2026
Obesity Crisis Hits Hardest Among U.S. Young Adults
New data challenges long-held assumptions about age and weight gain risk
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Health 14 Aug 2026
FDA's New Weight-Loss Pill Reshapes U.S. Obesity Drug Market
Eli Lilly's oral GLP-1 entry could pressure insurers and rivals as demand surges
Wegovy Pill Form Puts Pressure on U.S. Oral Drug Pipeline
Health 21 Jun 2026
Wegovy Pill Form Puts Pressure on U.S. Oral Drug Pipeline
Novo Nordisk's Wegovy pill formulation submission to the FDA is intensifying competition in the obesity drug market, prompting sc…
The Mental Health Emergency: How American States Are Responding to a Silent Crisis
Health 15 May 2026
The Mental Health Emergency: How American States Are Responding to a Silent Crisis
With federal action stalled, states are becoming the primary laboratories for addressing America's deepening mental health crisis…
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
Health 08 Jun 2026
Pancreatic Cancer Pill Reshapes U.S. Oncology Spending Debate
A new pancreatic cancer pill, Daraxonrasib, is reshaping U.S. oncology spending debates, offering a targeted therapy and challeng…
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Health 09 Jun 2026
Ozempic Muscle Loss Fuels U.S. Drug Pipeline Race
Ozempic and Wegovy-related muscle loss is spurring a major drug development race, with analysts predicting a $50+ billion market …
Weight-Loss Pill Boom Puts U.S. Insurers on Collision Course
Economy 06 Jul 2026
Weight-Loss Pill Boom Puts U.S. Insurers on Collision Course
Oral GLP-1 drugs enter market as coverage battles intensify across America
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Health 12 Jun 2026
Wegovy Pill Form Puts U.S. Oral GLP-1 Market on Notice
Novo Nordisk's Wegovy oral tablet formulation of semaglutide intensifies competition in the U.S. GLP-1 weight-loss drug market, s…
Cardiac Arrest Risk in Heat Puts U.S. Workplace Rules in Focus
Health 26 Jun 2026
Cardiac Arrest Risk in Heat Puts U.S. Workplace Rules in Focus
OSHA faces pressure to expand outdoor heat standards beyond elderly workers
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
Economy 08 Jul 2026
Weight-Loss Jabs Reshape U.S. Consumer Spending Patterns
GLP-1 drug surge quietly disrupts retail, food, and beverage sectors
Ozempic Maker's Ad War Signals New Front in U.S. Weight-Loss Market
Economy 22 Jul 2026
Ozempic Maker's Ad War Signals New Front in U.S. Weight-Loss Market
Novo Nordisk's suit against Eli Lilly could reshape pharma marketing rules
Weight-Loss Drugs Quietly Reshape U.S. Alcohol Industry Math
Society 09 Aug 2026
Weight-Loss Drugs Quietly Reshape U.S. Alcohol Industry Math
GLP-1 adoption surge threatens beer and spirits revenue as habits shift
Young Women's Type 2 Diabetes Surge Strains U.S. Prevention Push
Health 27 Jul 2026
Young Women's Type 2 Diabetes Surge Strains U.S. Prevention Push
CDC funding gaps leave clinics unprepared as diagnosis rates climb in women under 30
Topics: NHS Policy Ukraine War NHS Net Zero Starmer Zero League Artificial Intelligence Ukraine Senate Russia Champions Champions League Mental Health Renewable Energy Final Bill Grid Block Target Energy Security Council